924300-38-9

Basic information

• Product Name: 4-(2-hydroxy-2-methylpropoxy)-3,5-dimethyl benzonitrile
• Synonyms: 4-(2-hydroxy-2-methylpropoxy)-3,5-dimethyl benzonitrile
• CAS NO: 924300-38-9
• Molecular Weight: 219.283
• Mol File: 924300-38-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4-(2-hydroxy-2-methylpropoxy)-3,5-dimethyl benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-hydroxy-2-methylpropoxy)-3,5-dimethyl benzonitrile(924300-38-9)
• EPA Substance Registry System: 4-(2-hydroxy-2-methylpropoxy)-3,5-dimethyl benzonitrile(924300-38-9)

Safety Data

• Hazardous Substances Data: 924300-38-9(Hazardous Substances Data)

Upstream product

• 558-42-9 3-chloro-2-methylpropan-2-ol 
• 4198-90-7 3,5-dimethyl-4-hydroxybenzonitrile 

Downstream Products

• 924300-40-3 3-{4-[2-[(tert-butyl dimethylsilyl)oxy]-2-methylpropoxy]-3,5-dimethylphenyl}-6,8-dimethoxy-2H-isoquinolin-1-one 
• 924300-39-0 4-[2-(tert-butyldimethylsilanyloxy)-2-methylpropoxy]-3,5-dimethylbenzonitrile 

Relevant articles and documents

Used for the prevention and treatment of cardiovascular diseases

The invention relates to compounds that can be used for adjusting the expression of apolipoprotein A-I (ApoA-I) and usage of the compounds in treating and preventing cardiovascular diseases and related diseases, including the disorder related to cholesterol or lipids such as atherosclerosis.

COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.

PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF COMPLEX DISEASES AND THEIR DELIVERY BY INSERTABLE MEDICAL DEVICES

The present invention relates to polyphenol-like compounds that are useful for inhibiting VCAM-1 expression, MCP-1 expression and/or SMC proliferation in a mammal. The disclosed compounds are useful for regulating markers of inflammatory conditions, including vascular inflammation, and for treatment and prevention of inflammatory and cardiovascular diseases and related disease states.